Hochschulschrift
Pharmacokinetic/pharmacodynamic-guided optimisation of monoclonal antibody therapy in special populations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783844057645
3844057641
- Maße
-
21 cm, 311 g
- Umfang
-
xviii, 189 Seiten
- Ausgabe
-
[1. Auflage]
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen
Freie Universität Berlin, Dissertation, 2017
- Schlagwort
-
Crohn-Krankheit
Pharmakokinetik
Pharmakodynamik
Monoklonaler Antikörper
Infliximab
Crohn-Krankheit
Enteritis
Darmentzündung
Antikörper
B-Lymphozyt
Immunpharmakologie
Immunsuppressivum
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Shaker
- (wann)
-
2018
- Urheber
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Edlund, Helena
- Shaker Verlag
- Shaker
Entstanden
- 2018
Ähnliche Objekte (12)
Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
Non-Clinical Pharmacokinetic/Pharmacodynamic and Early Clinical Studies Supporting Development of a Novel Subcutaneous Formulation for the Monoclonal Antibody Rituximab
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Population pharmacokinetic analysis for the therapeutic anti-EGFR humanised monoclonal antibody matuzumab
Physiologically-based pharmacokinetic and mechanism-based pharmacodynamic modelling of monoclonal antibodies with a focus on tumour targeting
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
Monoclonal antibody therapy
A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis
Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
Non-Clinical Pharmacokinetic/Pharmacodynamic and Early Clinical Studies Supporting Development of a Novel Subcutaneous Formulation for the Monoclonal Antibody Rituximab
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Population pharmacokinetic analysis for the therapeutic anti-EGFR humanised monoclonal antibody matuzumab
Physiologically-based pharmacokinetic and mechanism-based pharmacodynamic modelling of monoclonal antibodies with a focus on tumour targeting
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
Monoclonal antibody therapy
A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis
Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
Non-Clinical Pharmacokinetic/Pharmacodynamic and Early Clinical Studies Supporting Development of a Novel Subcutaneous Formulation for the Monoclonal Antibody Rituximab
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Population pharmacokinetic analysis for the therapeutic anti-EGFR humanised monoclonal antibody matuzumab
Physiologically-based pharmacokinetic and mechanism-based pharmacodynamic modelling of monoclonal antibodies with a focus on tumour targeting
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
Monoclonal antibody therapy